I Bondarenko Selected Research

N-nitrosoethylenethiourea

7/2014

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Bondarenko Research Topics

Disease

8	Breast Neoplasms (Breast Cancer) 10/2021 - 03/2012
4	Melanoma (Melanoma, Malignant) 01/2020 - 01/2013
3	Disease Progression 10/2021 - 01/2018
3	Neutropenia 10/2021 - 08/2015
3	Adenocarcinoma 01/2021 - 08/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 03/2015
3	Hemorrhage 01/2018 - 01/2003
3	Neoplasms (Cancer) 01/2018 - 07/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2013
2	Febrile Neutropenia 01/2019 - 01/2018
2	Hand-Foot Syndrome 01/2018 - 10/2015
2	Vomiting 07/2014 - 07/2014
2	Nausea 07/2014 - 07/2014
2	Bone Resorption 03/2012 - 05/2003
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Mucositis 01/2019
1	Pathologic Complete Response 01/2018
1	Stomach Neoplasms (Stomach Cancer) 09/2017
1	Neoplasm Metastasis (Metastasis) 07/2017
1	Hepatocellular Carcinoma (Hepatoma) 04/2016
1	Liver Neoplasms (Liver Cancer) 04/2016
1	Heart Diseases (Heart Disease) 10/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2015
1	Hypertension (High Blood Pressure) 10/2015
1	Hypothyroidism 10/2015
1	Adenocarcinoma of Lung 08/2015
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011

Drug/Important Bio-Agent (IBA)

5	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 01/2013
4	Docetaxel (Taxotere)FDA Link 10/2021 - 08/2015
3	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2014
3	Trastuzumab (Herceptin)FDA Link 10/2021 - 01/2018
3	taxaneIBA 10/2021 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 10/2015 - 03/2012
2	PlatinumIBA 01/2022 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 10/2021 - 01/2019
2	pertuzumabIBA 10/2021 - 01/2019
2	dabrafenibIBA 11/2019 - 07/2017
2	trametinibIBA 11/2019 - 07/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2013
2	Fluorouracil (Carac)FDA LinkGeneric 09/2017 - 07/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2017 - 08/2015
2	Monoclonal AntibodiesIBA 04/2016 - 01/2013
2	netupitantIBA 07/2014 - 07/2014
2	Palonosetron (Aloxi)FDA Link 07/2014 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 03/2012 - 07/2011
2	Hormones (Hormone)IBA 05/2003 - 01/2003
2	Testosterone (Sustanon)FDA Link 05/2003 - 01/2003
2	Sex Hormone-Binding GlobulinIBA 05/2003 - 01/2003
2	Estradiol (Delestrogen)FDA LinkGeneric 05/2003 - 01/2003
2	Follicle Stimulating Hormone (Follitropin)FDA Link 05/2003 - 01/2003
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	human ERBB2 proteinIBA 10/2021
1	zolbetuximabIBA 01/2021
1	VemurafenibIBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2018
1	AnthracyclinesIBA 01/2018
1	bavituximabIBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Biosimilar PharmaceuticalsIBA 01/2018
1	veliparibIBA 01/2018
1	vinflunineIBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 04/2016
1	LigandsIBA 04/2016
1	mapatumumabIBA 04/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016
1	Abiraterone AcetateIBA 01/2016
1	Estrogen ReceptorsIBA 01/2016
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	exemestane (Aromasin)FDA Link 01/2016
1	Letrozole (Femara)FDA LinkGeneric 01/2016
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2016
1	Aromatase InhibitorsIBA 01/2016
1	nintedanibIBA 10/2015
1	Sunitinib (Sutent)FDA Link 10/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2015
1	STA 9090IBA 08/2015
1	figitumumabIBA 03/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2015
1	AntiemeticsIBA 07/2014
1	Aprepitant (Emend)FDA Link 07/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2014
1	Ondansetron (Zofran)FDA LinkGeneric 07/2014
1	N-nitrosoethylenethioureaIBA 07/2014
1	neratinibIBA 05/2013
1	IpilimumabIBA 01/2013
1	bosutinibIBA 03/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2011
1	Cetuximab (Erbitux)FDA Link 07/2011
1	Leucovorin (Folinic Acid)FDA Link 07/2011
1	OsteocalcinIBA 05/2003

Therapy/Procedure

9	Therapeutics 10/2021 - 07/2011
5	Drug Therapy (Chemotherapy) 01/2018 - 03/2012
1	Neoadjuvant Therapy 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Duration of Therapy 05/2013